Intuitive Surgical (ISRG) EVP Loeb reports new performance stock unit awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Intuitive Surgical executive Gary Loeb reported performance-based equity awards. On January 28, 2026, he acquired 2,543 performance stock units tied to a February 26, 2024 grant and 2,098 performance stock units tied to a February 28, 2023 grant, each at a stated price of 0.0 per unit.
The company’s compensation committee determined that required performance goals were achieved. The 2023-related units are scheduled to vest on February 28, 2026, and the 2024-related units on February 26, 2027, in each case contingent on Loeb’s continued service with Intuitive Surgical.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
LOEB GARY
Role
EVP & Chief Legal and Complian
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Stock Units - 2-26-2024 | 2,543 | $0.00 | -- |
| Grant/Award | Performance Stock Units - 2-28-2023 | 2,098 | $0.00 | -- |
Holdings After Transaction:
Performance Stock Units - 2-26-2024 — 2,543 shares (Direct);
Performance Stock Units - 2-28-2023 — 2,098 shares (Direct)
Footnotes (1)
- Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 26, 2024 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 26, 2027, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
FAQ
What insider transaction did Intuitive Surgical (ISRG) report for Gary Loeb?
Intuitive Surgical reported that executive Gary Loeb acquired performance stock units on January 28, 2026. He received 2,543 units from a 2024 grant and 2,098 units from a 2023 grant after their performance criteria were certified as achieved by the compensation committee.
Who is Gary Loeb in relation to Intuitive Surgical (ISRG)?
Gary Loeb is an officer of Intuitive Surgical, serving as EVP & Chief Legal and Compliance. The Form 4 shows he directly holds performance stock units awarded under prior grants, reflecting his role in the company’s leadership and long-term incentive compensation structure.
How many performance stock units did ISRG executive Gary Loeb acquire?
Gary Loeb acquired 2,543 performance stock units linked to a February 26, 2024 grant and 2,098 performance stock units linked to a February 28, 2023 grant. Both awards were reported at a stated price of zero per unit as part of equity incentive compensation.
When do Gary Loeb’s reported Intuitive Surgical performance stock units vest?
The performance stock units from the February 28, 2023 grant are scheduled to vest on February 28, 2026. Those from the February 26, 2024 grant are scheduled to vest on February 26, 2027. Vesting in both cases requires his continuous service with Intuitive Surgical through those dates.
What conditions apply to the Intuitive Surgical performance stock units granted to Gary Loeb?
Each performance stock unit grant was initially subject to specified performance metrics. The compensation committee has determined those criteria were achieved. The units will vest on their third anniversaries, in 2026 and 2027 respectively, provided Gary Loeb remains in continuous service with Intuitive Surgical.
Does the ISRG Form 4 show open-market stock purchases or sales by Gary Loeb?
The Form 4 reports acquisitions of performance stock units at a stated price of zero, not open-market purchases or sales of common stock. These are equity incentive awards linked to earlier grant dates and subsequent performance certification, rather than trading transactions in the public market.